Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Breast Cancer

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 93 articles: HTML format

Single Articles

February 2026
1. CRISTOFALO MM, Maesaka JY, Pereira DA, Nobrega GB, et al
   Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: A Systematic Review of Breast and Node Pathologic Response.
   J Surg Oncol. 2026 Feb 15. doi: 10.1002/jso.70213.
   PubMed     Abstract available
   
   
   January 2026
2. NGUYEN AT, Duckworth ED, Li RA, Galiano RD, et al
   Disparities in Breast Cancer Screening, Diagnosis, and Outcomes Among Vietnamese American Women: A Systematic Review.
   J Surg Oncol. 2026 Jan 14. doi: 10.1002/jso.70164.
   PubMed     Abstract available
   
   
   
3. HICKEY A, De la Cruz Ku G, King C, Franco C, et al
   Do Racial and Income Disparities Exist in the Application of 21-Gene Recurrence Score?
   J Surg Oncol. 2026;133:16-30.
   PubMed     Abstract available
   
   
   December 2025
4. ESGUEVA AJ, Tomatis M, Ponti A, Marotti L, et al
   Changing Practices in Axillary Surgery After Neoadjuvant Breast Cancer Therapy: Insights From the EUSOMA European Database.
   J Surg Oncol. 2025 Dec 18. doi: 10.1002/jso.70158.
   PubMed     Abstract available
   
   
   
5. DE LA CRUZ KU G, Desai A, Ho I, King C, et al
   Post-Operative Outcomes Across the Levels of Oncoplastic Breast Surgery According to the American Society of Breast Surgeons Oncoplastic Surgery Definition and Classification System.
   J Surg Oncol. 2025;132:1307-1316.
   PubMed     Abstract available
   
   
   November 2025
6. ALBUAINAIN RY, Althawadi R, Eid R, Abdulla HA, et al
   Oncological Outcomes of Omitting Axillary Surgery in Early Breast Cancer: A Systematic Review and Meta-Analysis.
   J Surg Oncol. 2025 Nov 26. doi: 10.1002/jso.70145.
   PubMed     Abstract available
   
   
   
7. AUBREY JM, Liefeld HR, Armstrong C, Levine A, et al
   Prospective Review of Practice Patterns in Breast Cancer Surgery Facilitates Rapid Practice Change, Reduced Clinical Variation, and Cost Savings.
   J Surg Oncol. 2025 Nov 16. doi: 10.1002/jso.70130.
   PubMed     Abstract available
   
   
   
8. DA SILVA LFCM, Carneiro FP, Motoyama AB
   MicroRNA Expression in Breast Cancer Patients, an Integrative Review.
   J Surg Oncol. 2025 Nov 16. doi: 10.1002/jso.70132.
   PubMed     Abstract available
   
   
   
9. WANG L, Zhou J, Zhao H
   Letter to the Editor: Comment on: "Factors Associated With Residual Positive Lymph Nodes With Targeted Axillary Lymph Node Dissection for Breast Cancer and Accuracy of Clipped Node Retrieval in Non-Mapping Patients".
   J Surg Oncol. 2025 Nov 6. doi: 10.1002/jso.70126.
   PubMed    
   
   
   
10. GOLDHABER NH, O'Keefe TJ, Longo L, Blair SL, et al
    Effect of Neoadjuvant Hormonal Therapy on Breast Conservation in Invasive Ductal Versus Lobular Carcinoma of the Breast: A Comparative Analysis.
    J Surg Oncol. 2025;132:1011-1018.
    PubMed     Abstract available
    
    
    
11. GHOSH K, Kuchta K, Alva D, Seth AK, et al
    Is Prepectoral Implant Reconstruction Associated With Better Physical Well-Being?
    J Surg Oncol. 2025;132:1071-1075.
    PubMed     Abstract available
    
    
    October 2025
12. ALTUNDAG K
    Liquid Biopsy in Metastatic Breast Cancer: Adoption Lags Despite Growing Evidence.
    J Surg Oncol. 2025 Oct 10. doi: 10.1002/jso.70107.
    PubMed    
    
    
    
13. KIM M, Gilliland JL, Jiang CZ, Parnes MF, et al
    Sexual Health in Postmastectomy Breast Reconstruction Patients and Value of an Intervention: A Qualitative Study.
    J Surg Oncol. 2025;132:825-835.
    PubMed     Abstract available
    
    
    
14. WANG X, Shao Z, Zhu H, Zhang Q, et al
    Evolving Trends in Postmastectomy Breast Reconstruction With Autologous Tissues: A Large-Scale, 24-Year Retrospective Study in China.
    J Surg Oncol. 2025;132:845-852.
    PubMed     Abstract available
    
    
    September 2025
15. REDAELLI M, Steadman JA, Hoskin TL, Hieken TJ, et al
    Does RECIST 1.1 Predict Nodal Response to Neoadjuvant Chemo-Immunotherapy in Breast Cancer?
    J Surg Oncol. 2025 Sep 24. doi: 10.1002/jso.70096.
    PubMed     Abstract available
    
    
    
16. ZHANG X, Chen Y, Wu Q, Yu Y, et al
    Safety Analysis of Omitting Radiotherapy After Breast-Conserving Surgery in Patients With Early-Stage Breast Cancer: A Meta-Analysis Based on Randomized Controlled Trials.
    J Surg Oncol. 2025 Sep 20. doi: 10.1002/jso.70091.
    PubMed     Abstract available
    
    
    
17. NGUYEN AT, Li RA, Ontiveros NC, Adam TH, et al
    Utility of the Social Vulnerability Index in Addressing Breast Cancer Disparities: A Meta-Analysis.
    J Surg Oncol. 2025 Sep 20. doi: 10.1002/jso.70080.
    PubMed     Abstract available
    
    
    
18. EPHRAIM R, Kar M, Sultania M, Naik S, et al
    Factors Influencing the Choice of Mastectomy Over Breast Conservation Surgery in Early Breast Cancer: A Prospective Qualitative Exploration of Patient Perspectives From India.
    J Surg Oncol. 2025 Sep 14. doi: 10.1002/jso.70088.
    PubMed     Abstract available
    
    
    August 2025
19. BRABENDER DE, Griffiths A, Lu KA, Armstrong K, et al
    Factors Associated With Residual Positive Lymph Nodes With Targeted Axillary Lymph Node Dissection for Breast Cancer and Accuracy of Clipped Node Retrieval in Non-Mapping Patients.
    J Surg Oncol. 2025 Aug 21. doi: 10.1002/jso.70070.
    PubMed     Abstract available
    
    
    
20. LIU P, Liu Y, Xie Y, Hu S, et al
    Potential of Combination of CE-MRI and Serum Her-2neu Extracellular Domain in Evaluating Effectiveness of Neoadjuvant Chemotherapy in Breast Cancer.
    J Surg Oncol. 2025 Aug 11. doi: 10.1002/jso.70058.
    PubMed     Abstract available
    
    
    
21. KIM M, Bubberman J, Amakiri U, Kim YS, et al
    Culture Impacts Sexual Well-Being in Autologous Breast Reconstruction: A Multi-Continental Examination.
    J Surg Oncol. 2025;132:375-383.
    PubMed     Abstract available
    
    
    
22. GABAY AJ, Chen J, Stern CS, Gibbons C, et al
    Predicting Breast Reconstruction Readmission, Reoperation, and Prolonged Length of Stay: A Machine Learning Approach.
    J Surg Oncol. 2025;132:345-353.
    PubMed     Abstract available
    
    
    
23. LEVY J, Amakiri U, Shammas RL, Graziano FD, et al
    Longitudinal Modeling in Surgical Oncology Research: A Primer Examining Patient-Reported Outcomes.
    J Surg Oncol. 2025;132:294-307.
    PubMed     Abstract available
    
    
    July 2025
24. SUPPAN I, Lundon D, Garg PK, Caballero C, et al
    Clinical Use of Liquid Biopsy in Metastatic Breast Cancer-An ESSO-EYSAC International Survey.
    J Surg Oncol. 2025 Jul 14. doi: 10.1002/jso.70045.
    PubMed     Abstract available
    
    
    
25. WILLERT CB, Bidstrup P, Mellemkjaer L, Kalstrup J, et al
    Bilateral Risk-Reducing Mastectomy With Immediate Breast Reconstruction Lowers Concerns of Breast Cancer in Women With a High-Risk Genetic Predisposition for Breast Cancer Compared With a Radiological Imaging Surveillance Group.
    J Surg Oncol. 2025 Jul 9. doi: 10.1002/jso.70029.
    PubMed     Abstract available
    
    
    
26. WAREHAM C, Bertaux B, Chahine E, Homsy C, et al
    Geographical Presence of Plastic Surgeons in Relation to Breast Surgeons in the United States for Breast Reconstruction.
    J Surg Oncol. 2025;132:22-27.
    PubMed     Abstract available
    
    
    June 2025
27. FANNING JE, Chen A, Thomson S, Tillotson E, et al
    Epitrochlear and Humeral Lymph Nodes: A Biomarker for Deep Lymphatic Function and Implications for Breast Cancer-Related Lymphedema Risk.
    J Surg Oncol. 2025 Jun 24. doi: 10.1002/jso.70002.
    PubMed     Abstract available
    
    
    
28. VARAGUR K, Ribaudo JG, Keller M, Fadell NR, et al
    Understanding Trends in Incidence and Management of Pregnancy-Associated Breast Cancer in a National Sample Using Claims Data.
    J Surg Oncol. 2025 Jun 19. doi: 10.1002/jso.70010.
    PubMed     Abstract available
    
    
    
29. VASCONCELOS CS, Salgado MRT, Martins MR, Anunciacao CEC, et al
    Soluble sFas, sFasL, sPD1, and sPDL1 Analyses in the Peripheral Blood of Locally Advanced Breast Cancer Patients Before and After Neoadjuvant Chemotherapy.
    J Surg Oncol. 2025 Jun 2. doi: 10.1002/jso.27723.
    PubMed     Abstract available
    
    
    
30. COLEMAN-BELIN JC, Kim M, Graziano FD, Boe LA, et al
    Combined Autologous Breast Reconstruction and Gynecologic Procedures: Does Timing Affect Clinical and Patient-Reported Outcomes?
    J Surg Oncol. 2025;131:1400-1406.
    PubMed     Abstract available
    
    
    
31. STERN CS, Shammas RL, Montes ES, Boe LA, et al
    Improving the Evaluation of Aesthetic Outcomes in DIEP Flap Breast Reconstruction: Validation of the Aesthetic Grading Tool.
    J Surg Oncol. 2025;131:1407-1412.
    PubMed     Abstract available
    
    
    
32. HUANG A, Koesters E, Garza RM, Hanson SE, et al
    A Single Institution Experience With Immediate Lymphatic Reconstruction: Impact of Insurance Coverage on Risk Reduction.
    J Surg Oncol. 2025;131:1393-1399.
    PubMed     Abstract available
    
    
    
33. NGUYEN A, Chon J, Coles B, Galiano R, et al
    Disparities in Breast Reconstruction After Mastectomy in Southeast Asia: A Systematic Review.
    J Surg Oncol. 2025;131:1601-1619.
    PubMed     Abstract available
    
    
    May 2025
34. VAN DECAR SG, Barbera EL, Adams AM, Shore JM, et al
    A Validated Ultrasound-Based Scoring System to Stratify Risk of Axillary Metastasis in Breast Cancer: AX-RADS (Axillary Imaging Reporting and Data System).
    J Surg Oncol. 2025 May 20. doi: 10.1002/jso.28159.
    PubMed     Abstract available
    
    
    
35. DALY GE, Collins KL, Malone SE, Garreau J, et al
    Incidence of Deleterious Genetic Mutations in Newly Diagnosed Breast Cancer Patients Over the Age of 65: Is It Time to Expand Testing Parameters?
    J Surg Oncol. 2025 May 13. doi: 10.1002/jso.28151.
    PubMed     Abstract available
    
    
    
36. CANO-LALLAVE E, Frutos-Bernal E, Anciones-Polo M, Serrano-Sanchez E, et al
    Optimizing Lymphedema Management After Breast Cancer: Predictive Risk Models in Clinical Practice.
    J Surg Oncol. 2025 May 13. doi: 10.1002/jso.28146.
    PubMed     Abstract available
    
    
    
37. GRAZIANO FD, White DR, Plotsker EL, Shammas RL, et al
    Enhancing Patient Decision-Making in Breast Reconstruction: A Systematic Review of Decision Aid Efficacy.
    J Surg Oncol. 2025;131:1222-1235.
    PubMed     Abstract available
    
    
    
38. ZINDANI S, Khalil M, Rashid Z, Altaf A, et al
    Association of Socio-Environmental Burden and Inequality With Cancer Screening and Mortality.
    J Surg Oncol. 2025;131:1110-1117.
    PubMed     Abstract available
    
    
    
39. KIEFER J, Paidisetty P, Elmorsi RAI, Nguyen CHM, et al
    Contemporary Trends in Reconstruction for Patients With Sarcoma of the Breast.
    J Surg Oncol. 2025;131:1013-1023.
    PubMed     Abstract available
    
    
    
40. GRAZIANO FD, Amakiri UO, Levy J, Shammas RL, et al
    Perioperative Venous Thromboembolism Chemoprophylaxis Does Not Increase Risk of Complications in Free Flap Breast Reconstruction.
    J Surg Oncol. 2025;131:1211-1221.
    PubMed     Abstract available
    
    
    April 2025
41. DAVE N, Hajj JP, Ahmed S, Hulsman L, et al
    Immediate Breast Reconstruction for Inflammatory Breast Carcinoma: A Scoping Review.
    J Surg Oncol. 2025;131:775-781.
    PubMed     Abstract available
    
    
    March 2025
42. CHIU CW, Su CM, Liao LM, Su CS, et al
    Upstaging Prediction Model to Guide the Application of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma In Situ: A Retrospective Comparative Study.
    J Surg Oncol. 2025;131:571-579.
    PubMed     Abstract available
    
    
    February 2025
43. CLARK P, DiPasquale A, Cocco D, Brown A, et al
    Oncoplastic Surgery: Where Are We Now?
    J Surg Oncol. 2025;131:124-132.
    PubMed     Abstract available
    
    
    
44. MCADAMS CD, Clevenger N, Nicholson K, Pesce C, et al
    Proportion of Patients With Ductal Carcinoma In Situ That Qualify for Observation Criteria Set Forth by Clinical Trials.
    J Surg Oncol. 2025;131:115-123.
    PubMed     Abstract available
    
    
    
45. LEFF DR
    Technologies and techniques to improve precision in breast conserving surgery.
    J Surg Oncol. 2025;131:108-114.
    PubMed     Abstract available
    
    
    January 2025
46. DE LA CRUZ KU G, Desai A, Hickey A, Valcarcel B, et al
    Disparities in Triple Negative Breast Cancer Among Hispanic Population Living in Latin America Versus the United States.
    J Surg Oncol. 2025 Jan 13. doi: 10.1002/jso.28088.
    PubMed     Abstract available
    
    
    December 2024
47. ARREY EN, GoPaul D, Anderson D, Okoli J, et al
    Addressing Breast Cancer Disparities: A Comprehensive Approach to Health Equity.
    J Surg Oncol. 2024 Dec 19. doi: 10.1002/jso.28011.
    PubMed     Abstract available
    
    
    
48. WANG X, Jin J, Zhu Y, Liu X, et al
    Letter to "Body Mass Index and Breast Cancer-Related Lymphedema: A Retrospective Cohort Study".
    J Surg Oncol. 2024 Dec 19. doi: 10.1002/jso.28055.
    PubMed    
    
    
    
49. LI F, Wei Y, Li L, Chen F, et al
    Collagen Density Is Associated With Pathological Complete Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.
    J Surg Oncol. 2024 Dec 19. doi: 10.1002/jso.28046.
    PubMed     Abstract available
    
    
    
50. NAJAFALI D, Siotos C, Kokosis G
    Taxanes and Breast Cancer-Related Lymphedema.
    J Surg Oncol. 2024 Dec 15. doi: 10.1002/jso.28017.
    PubMed    
    
    
    November 2024
51. NGUYEN A, Duckworth E, Pascua D, Coles B, et al
    Disparities in Breast Cancer Treatment and Reconstruction Among Native Hawaiian and Pacific Islander Women: Systematic Review and Meta-Analysis.
    J Surg Oncol. 2024 Nov 25. doi: 10.1002/jso.27994.
    PubMed     Abstract available
    
    
    
52. HANNOUN-LEVI JM, Polgar C, Strnad V, Gutierrez C, et al
    With Regard to Schwieger L. et al. Intraoperative Radiation Therapy for Early-Stage Breast Cancer. DOI: 101002/jso27814.
    J Surg Oncol. 2024 Nov 11. doi: 10.1002/jso.27971.
    PubMed    
    
    
    October 2024
53. MCSHANE N, Zaborowski A, O'Reilly M, McCartan D, et al
    Hormone Receptor Positive Breast Cancer in Young Women: A Review.
    J Surg Oncol. 2024 Oct 29. doi: 10.1002/jso.27963.
    PubMed     Abstract available
    
    
    
54. JIANG Q, Hu H, Liao J, Duan P, et al
    Body Mass Index and Breast Cancer-Related Lymphedema: A Retrospective Cohort Study.
    J Surg Oncol. 2024 Oct 28. doi: 10.1002/jso.27969.
    PubMed     Abstract available
    
    
    
55. HANSSEN D, Champion N, Ngo J, Palfi S, et al
    Frailty and Malnutrition in Surgical Outcomes of Elderly Breast Cancer Patients.
    J Surg Oncol. 2024 Oct 10. doi: 10.1002/jso.27940.
    PubMed     Abstract available
    
    
    
56. LIU C, Zhao H, Zhou Y
    Comment On: "Factors Influencing Prophylactic Surgical Intervention in Women With Genetic Predisposition for Breast Cancer".
    J Surg Oncol. 2024 Oct 8. doi: 10.1002/jso.27930.
    PubMed    
    
    
    September 2024
57. ALTUNDAG K
    The Association of Taxanes With Breast Cancer-Related Lymphedema.
    J Surg Oncol. 2024 Sep 19. doi: 10.1002/jso.27906.
    PubMed    
    
    
    
58. KU GC, Wareham C, King C, Koul A, et al
    Is Oncoplastic Surgery Safe in High-Risk Breast Cancer Phenotypes?
    J Surg Oncol. 2024 Sep 16. doi: 10.1002/jso.27899.
    PubMed     Abstract available
    
    
    
59. ZHAO H, Xu J, Zhou Y
    Comment On: "Assessing Breast Cancer-Related Lymphedema Screening and Treatment Gaps in a Safety-Net Hospital".
    J Surg Oncol. 2024 Sep 9. doi: 10.1002/jso.27894.
    PubMed    
    
    
    
60. HUMAR P, Balogun Z, Douglas N, Glenney A, et al
    Factors influencing prophylactic surgical intervention in women with genetic predisposition for breast cancer.
    J Surg Oncol. 2024 Sep 1. doi: 10.1002/jso.27817.
    PubMed     Abstract available
    
    
    
61. SELBY LV, Clark E, Chen JL, Tinoco G, et al
    Use of neoadjuvant paclitaxel in breast angiosarcoma-Impact on surgical resection and response rates.
    J Surg Oncol. 2024;130:579-585.
    PubMed     Abstract available
    
    
    August 2024
62. SCHWIEGER L, Switchenko JM, Cao Y, Amaniera I, et al
    Intraoperative radiation therapy for early-stage breast cancer.
    J Surg Oncol. 2024 Aug 29. doi: 10.1002/jso.27814.
    PubMed     Abstract available
    
    
    
63. SIOTOS C, Arnold SH, Seu M, Lunt L, et al
    Breast cancer-related lymphedema: A comprehensive analysis of risk factors.
    J Surg Oncol. 2024 Aug 27. doi: 10.1002/jso.27841.
    PubMed     Abstract available
    
    
    
64. ALTUNDAG K
    Women with breast cancer who have second primary malignancies: Further information is still needed.
    J Surg Oncol. 2024 Aug 9. doi: 10.1002/jso.27809.
    PubMed    
    
    
    
65. STEADMAN JA, Hieken TJ
    Advances from targeted therapy for non-metastatic HER2-positive inflammatory breast cancer.
    J Surg Oncol. 2024 Aug 5. doi: 10.1002/jso.27797.
    PubMed     Abstract available
    
    
    
66. LOU Y, Qu M
    Letter to the Editor: Comment on: "Reliability of artificial intelligence chatbot responses to frequently asked questions in breast surgical oncology".
    J Surg Oncol. 2024;130:347-348.
    PubMed    
    
    
    
67. YANG AZ, Hyland CJ, Miller AS, Killelea BK, et al
    Local practice variations and payer differences underlie state-wide disparities in oncoplastic breast surgery.
    J Surg Oncol. 2024;130:210-221.
    PubMed     Abstract available
    
    
    
68. DAUNGSUPAWONGM H, Wiwanitkit V
    Reliability of artificial intelligence chatbot responses to frequently asked questions in breast surgical oncology: Correspondence.
    J Surg Oncol. 2024;130:338.
    PubMed    
    
    
    
69. ROLDAN-VASQUEZ E, Mitri S, Bhasin S, Bharani T, et al
    Reliability of artificial intelligence chatbot responses to frequently asked questions in breast surgical oncology.
    J Surg Oncol. 2024;130:188-203.
    PubMed     Abstract available
    
    
    July 2024
70. CHEN C, Tseng J, Amersi F, Silberman AW, et al
    Second primary malignancies in women with breast cancer.
    J Surg Oncol. 2024 Jul 19. doi: 10.1002/jso.27785.
    PubMed     Abstract available
    
    
    
71. GARAYUA-CRUZ L, Broida SE, Okuno SH, Robinson SI, et al
    Outcomes of non-angiosarcoma radiation-associated soft tissue sarcomas of the chest.
    J Surg Oncol. 2024;130:56-63.
    PubMed     Abstract available
    
    
    
72. UPADHYAY N, Wolska J
    Imaging the dense breast.
    J Surg Oncol. 2024;130:29-35.
    PubMed     Abstract available
    
    
    
73. BOLAND MR
    Modern management of the axilla.
    J Surg Oncol. 2024;130:23-28.
    PubMed     Abstract available
    
    
    June 2024
74. HYAMS DM, Bareket-Samish A, Rocha JEB, Diaz-Botero S, et al
    Selecting postoperative adjuvant systemic therapy for early-stage breast cancer: An updated assessment and systematic review of leading commercially available gene expression assays.
    J Surg Oncol. 2024 Jun 24. doi: 10.1002/jso.27692.
    PubMed     Abstract available
    
    
    
75. KELLEY K, Sener SF
    Who still needs surgical staging of the axilla for invasive breast cancer?
    J Surg Oncol. 2024 Jun 21. doi: 10.1002/jso.27753.
    PubMed     Abstract available
    
    
    
76. YOUNG S, Geary A, Zhao X, Kenzik K, et al
    Assessing breast cancer-related lymphedema screening and treatment gaps in a safety-net hospital.
    J Surg Oncol. 2024 Jun 14. doi: 10.1002/jso.27735.
    PubMed     Abstract available
    
    
    
77. SALGADO MRT, Sobral DV, Martins MR, Salgado EFMT, et al
    Expression of CD28, FAS, PD1, and CTLA4 molecules in the blood of women with triple-negative breast cancer.
    J Surg Oncol. 2024 Jun 6. doi: 10.1002/jso.27725.
    PubMed     Abstract available
    
    
    
78. SOBRAL DV, Salgado MRT, Martins MR, Vasconcelos CS, et al
    Prognostic role of SOX2 and STAT3 expression on circulating T lymphocytes and CD44+/CD24(neg) cells in the locally advanced and metastatic breast cancer.
    J Surg Oncol. 2024 Jun 2. doi: 10.1002/jso.27716.
    PubMed     Abstract available
    
    
    
79. CHEN JC, Handley D, Elsaid MI, Fisher JL, et al
    Racial disparities in disease-specific mortality and surgical management of patients with ductal carcinoma in situ with microinvasion.
    J Surg Oncol. 2024;129:1179-1186.
    PubMed     Abstract available
    
    
    
80. AMBIKA M, Lara S, Faulkner HR, Toncred S, et al
    Oncoplastic reconstruction with breast-conserving treatment versus breast-conserving treatment alone in the elderly.
    J Surg Oncol. 2024;129:1187-1191.
    PubMed     Abstract available
    
    
    
81. KIM M, Vingan P, Boe LA, Tadros AB, et al
    Nonresponse data in sexual well-being among breast reconstruction patients-who are we overlooking?
    J Surg Oncol. 2024;129:1192-1201.
    PubMed     Abstract available
    
    
    
82. REYES-MONASTERIO A, Moller MG, Lozada-Martinez ID, Narvaez-Rojas AR, et al
    Bridging frontiers: The role of a Global Breast Research Working Group.
    J Surg Oncol. 2024;129:1507-1514.
    PubMed     Abstract available
    
    
    
83. KIM M, Ali B, Graziano FD, Colvin K, et al
    Analyzing mastectomy and reconstruction weight in immediate autologous breast reconstruction: A preliminary study.
    J Surg Oncol. 2024;129:1466-1474.
    PubMed     Abstract available
    
    
    May 2024
84. DI PACE B, Padley RH
    Enhancing treatment compliance in breast cancer patients: A multi-faceted approach.
    J Surg Oncol. 2024 May 27. doi: 10.1002/jso.27679.
    PubMed    
    
    
    
85. DI PACE B, Padley RH
    Breast cancer survivorship: A viewpoint.
    J Surg Oncol. 2024 May 19. doi: 10.1002/jso.27680.
    PubMed    
    
    
    
86. KEATING N, Cevik J, Hopkins D, Lippey J, et al
    Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia: A systematic review and meta-analysis.
    J Surg Oncol. 2024;129:1025-1033.
    PubMed     Abstract available
    
    
    
87. SPIEKERMAN VAN WEEZELENBURG MA, Daemen JHT, van Kuijk SMJ, van Haaren ERM, et al
    Seroma formation after mastectomy: A systematic review and network meta-analysis of different flap fixation techniques.
    J Surg Oncol. 2024;129:1015-1024.
    PubMed     Abstract available
    
    
    
88. DI PACE B, Padley RH
    Survivorship and breast cancer: Navigating the continuum of care.
    J Surg Oncol. 2024 May 1. doi: 10.1002/jso.27671.
    PubMed    
    
    
    April 2024
89. ABAHSSAIN H, Souadka A
    Navigating the complexity of post-NAT therapy in breast cancer: The role of ctDNA testing.
    J Surg Oncol. 2024 Apr 23. doi: 10.1002/jso.27658.
    PubMed    
    
    
    
90. NTOWE KW, Lee MS, Plichta JK
    Clinical genetics in breast cancer.
    J Surg Oncol. 2024 Apr 1. doi: 10.1002/jso.27630.
    PubMed     Abstract available
    
    
    
91. SPIEKERMAN VAN WEEZELENBURG MA, de Rooij L, Aldenhoven L, van Kuijk SMJ, et al
    Drain-free mastectomy and flap fixation: The interim analysis of a randomized controlled noninferiority trial.
    J Surg Oncol. 2024;129:975-980.
    PubMed     Abstract available
    
    
    March 2024
92. VALENTE S, Roesch E
    Breast cancer survivorship.
    J Surg Oncol. 2024 Mar 27. doi: 10.1002/jso.27627.
    PubMed     Abstract available
    
    
    December 2023
93. ROCHLIN DH, Matros E, Shamsunder MG, Rubenstein R, et al
    Plastic surgery market share of breast reconstructive procedures: An analysis of two nationwide databases.
    J Surg Oncol. 2023;128:1064-1071.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum